步步高(002251.SZ):控股股東籌劃控制權變更事宜 股票停牌
格隆匯1月9日丨步步高(002251.SZ)公佈,公司於2023年1月8日接到控股股東步步高集團通知,獲悉步步高集團正在籌劃股份轉讓及表決委託權事宜,合計股份轉讓及表決委託權比例佔公司總股本的29.00%(具體比例及交易方式待交易雙方進一步商議確定),涉及公司控制權變更。該次交易對手方屬於地方政府產業投資平台,主要從事產業投資業務。公司股票於2023年1月9日開市起停牌,預計停牌時間不超過2個交易日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.